Getting to zero quickly in the 2019-nCov epidemic with vaccines or rapid testing
Chowell, G.; Dhillon, R.; Srikrishna, D.
Show abstract
Any plan for stopping the ongoing 2019-nCov epidemic must be based on a quantitative understanding of the proportion of the at-risk population that needs to be protected by effective control measures in order for transmission to decline sufficiently and quickly enough for the epidemic to end. Using an SEIR-type transmission model, we contrasted two alternate strategies by modeling the proportion of the population that needs to be protected from infection by one-time vaccination (assuming 100% effectiveness) or by testing with isolation and treatment of individuals within six, 24, or 48 hours of symptom onset. If R is currently 2.2, vaccination at the herd immunity coverage of 55% would drive R just below 1, but transmission could persist for years. Over 80% of coverage is required to end the epidemic in 6 months with population-wide vaccination. The epidemic could be ended in just under a year if testing with isolation and treatment reached 80% of symptomatically infected patients within 24 hours of symptom onset (assuming 10% asymptomatic transmission). The epidemic could be ended in six months if testing with isolation and treatment reached 90% of symptomatic patients. If 90% of symptomatic patients could be tested within six hours of symptoms appearing, the epidemic could be ended in under four months.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Reducing RSV hospitalisation in a lower-income country by vaccinating mothers-to-be and their households 94%
- Selection for infectivity profiles in slow and fast epidemics, and the rise of SARS-CoV-2 variants 93%
- Estimating the transmissibility of SARS-CoV-2 during periods of high, low and zero case incidence 93%
Similar papers in this journal
- Beyond the new normal: assessing the feasibility of vaccine-based elimination of SARS-CoV-2 95%
- Test-trace-isolate-quarantine (TTIQ) intervention strategies after symptomatic COVID-19 case identification 94%
- The impact of COVID-19 vaccination campaigns accounting for antibody-dependent enhancement 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.